The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引：50

作者：

Khezri, Mohammad Rafi ^{[1
]}

Jafari, Reza ^{[2
]}

Yousefi, Keyvan ^{[3
]}

Zolbanin, Naime Majidi ^{[4
,5
,6
]}

机构：

[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran

[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran

[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA

[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran

[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran

[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran

来源：

EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2022年 / 127卷

关键词：

Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;

D O I：

10.1016/j.yexmp.2022.104787

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.

引用

页数：12

共 50 条

[31] Towards Enhancing Therapeutic Glycoprotein Bioproduction: Interventions in the PI3K/AKT/mTOR Pathway
Mahameed, Mohamed
Sulieman, Afnan
Alkam, Duah
Tirosh, Boaz
CELL STRUCTURE AND FUNCTION, 2019, 44 (02) : 75 - 83
[32] Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Polivka, Jiri, Jr.
Janku, Filip
PHARMACOLOGY & THERAPEUTICS, 2014, 142 (02) : 164 - 175
[33] Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
Zarneshan, Seyede Nazanin
Fakhri, Sajad
Farzaei, Mohammad Hosein
Khan, Haroon
Saso, Luciano
FOOD AND CHEMICAL TOXICOLOGY, 2020, 145
[34] Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
Ching, Christina Barbara
Hansel, Donna Elizabeth
LABORATORY INVESTIGATION, 2010, 90 (10) : 1406 - 1414
[35] The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
Cheaib, Bianca
Auguste, Aurelie
Leary, Alexandra
CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 4 - 16
[36] Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Chen Xue
Ganglei Li
Juan Lu
Lanjuan Li
Signal Transduction and Targeted Therapy, 6
[37] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
Na Li
Fan Yang
Dong-Yan Liu
Jin-Tao Guo
Nan Ge
Si-Yu Sun
World Journal of Gastrointestinal Oncology, 2021, (09) : 1164 - 1183
[38] The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions
Khorasani, Ayda Baghery Saghchy
Pourbagheri-Sigaroodi, Atieh
Pirsalehi, Ali
Safaroghli-azar, Ava
Zali, Mohammad Reza
Bashash, Davood
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 898
[39] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Leiphrakpam, Premila D.
Are, Chandrakanth
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
[40] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
Li, Na
Yang, Fan
Liu, Dong-Yan
Guo, Jin-Tao
Ge, Nan
Sun, Si-Yu
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (09) : 1164 - 1183

← 1 2 3 4 5 →